(Q73025439)
Statements
Daily subcutaneous ultra-low-dose interleukin 2 with daily low-dose interferon-alpha in patients with advanced renal cell carcinoma (English)
J I Clark
E R Gaynor
B Martone
S C Budds
R Manjunath
R C Flanigan
W B Waters
1 September 1999